Corporate Ethics
Corporate Ethics

Compliance Hotline

Jazz Pharmaceuticals has established various methods of confidential communication for our employees, vendors and others to report suspected violations of laws, rules, regulations or company policies. Where permitted by local laws, anonymous reporting is available through this link or through the toll-free numbers listed below.

To email us:

To call us:

North America: 1-800-511-2034
Austria: 0800-291870
Belgium: 0800-77004
Canada (English): 1-800-511-2034
Canada (French): 1-855-350-9393
France: 0800-902500
Germany: 0800-1016582
Ireland: 1-800615403
Italy: 800-786907
Netherlands: 0800-0226174
Poland: 0-0-800-1211571
Portugal: 8008-12499
Spain: 900-991498
United Kingdom: 0800-032-8483

To write to us: Jazz Pharmaceuticals plc
c/o Jazz Pharmaceuticals, Inc.
3180 Porter Drive
Palo Alto, CA 94304
Attn: Chief Compliance Officer

Comprehensive Compliance Program

Compliance with applicable laws, rules and regulations in the countries where we do business is an overriding principle of Jazz Pharmaceuticals’ corporate culture.  The company’s commitment to ethical behavior is implemented through comprehensive compliance policies, employee training and monitoring programs and an open-door policy for reporting suspected violations.  Read more about our Compliance Program below.

Comprehensive Compliance Program As part of Jazz Pharmaceuticals’ continuing commitment to corporate compliance, Jazz Pharmaceuticals declares that, to the best of its knowledge, and based on a good faith understanding of the statutory requirements of California Health and Safety Code § 119400 and 119402, it has adopted a Comprehensive Compliance Program as mandated by this California law. To the best of our knowledge, as of July 1, 2017, Jazz Pharmaceuticals believes that it is in compliance with its Comprehensive Compliance Program and its good faith understanding of the requirements of California Health and Safety Code § 119400 and 119402.

For questions about our Comprehensive Compliance Program or to obtain a copy, please contact us at

Code of ConductOn October 30, 2014, the Board of Directors of Jazz Pharmaceuticals plc amended and restated the Code of Conduct that applies to all of Jazz Pharmaceuticals’ directors, officers and employees (“Covered Personnel”). The principal purpose of the amendment and restatement was to provide additional guidance to Covered Personnel regarding the available channels for reporting of possible legal or policy violations, to bring certain provisions of the Code of Conduct into conformity with certain legal requirements in jurisdictions outside the United States and other existing policies and procedures of the Company and to make certain other technical and administrative changes. The revisions to the Code of Conduct did not relate to or result in any waiver, explicit or implicit, of any provision of the Code of Conduct in effect prior to its amendment and restatement.

Anti-Corruption PolicyJazz is committed to comply with applicable anti-corruption and anti-bribery laws, including the Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act (UKBA).  To help ensure compliance with these laws, Jazz has adopted a global Anti-Corruption Policy that applies to all employees of the company, its subsidiaries and affiliates, and third party vendors and other agents acting on our behalf.

Supply Chain Transparency

Jazz Pharmaceuticals plc and its subsidiaries (“Jazz” or “the Company”) are committed to operating our global business with integrity and upholding a high level of ethical conduct among our employees and business partners. We expect that suppliers which provide materials for use in our tangible goods for sale (“Product Suppliers”) to adopt sound human rights practices, to treat workers fairly, with dignity and respect and in all cases to eliminate human trafficking and slavery in their workplace.

Jazz Pharmaceuticals' Standards of Conduct for Supply Chain

The following Slavery and Human Trafficking Statement is intended to be responsive to the California Transparency in Supply Chains Act of 2010 and the UK Modern Slavery Act of 2015.

Verification: Jazz has existing procedures for assessing our Product Suppliers and is in the process of enhancing these procedures to include steps for evaluating whether our Product Suppliers comply with applicable laws related to eradication of human trafficking, slavery and illegal child labor. Our Supply Chain and Quality Assurance teams oversee these verification procedures using an internally-developed multi-part assessment. In addition, Jazz has adopted written Standards of Conduct for Supply Chain and will request that our Product Suppliers certify that they comply with applicable laws concerning human trafficking, slavery and illegal child labor in the countries in which they do business.

Audits: Jazz conducts periodic and regular announced audits of its Product Suppliers to evaluate their compliance with Jazz’s policies and applicable legal and regulatory requirements. Jazz typically conducts such audits using its own personnel, although it reserves the right to engage an independent third party auditor. Jazz’s current Contract Manufacturer Assessment Guidelines establish procedures for audits of potential and existing Product Suppliers, including their training, experience and qualifications, adherence to legal and regulatory requirements, and evaluation of the suppliers’ compliance with quality systems. Jazz tracks any observations and/or non-compliance in its Audit Follow Up & Close-Out procedures to ensure that instances of non-compliance are properly remediated. Jazz is currently in the process of considering further elaboration of its Contract Manufacturer Assessment Guidelines to expressly address human trafficking, slavery and illegal child labor in its auditing protocol.

Materials: Jazz is in the process of implementing procedures that will require Product Suppliers to certify that materials incorporated into Jazz’s products comply with the laws regarding human trafficking, slavery and illegal child labor in applicable countries.

Accountability Standards: Jazz is in the process of establishing internal accountability standards and procedures, including disciplinary action for its employees and contractors with procurement responsibilities who fail to meet Jazz’s standards regarding identification and elimination of human trafficking, slavery and illegal child labor in its supply chain.

Training: Jazz has developed and provides training for its employees and management who have direct responsibility for supply chain management, particularly with respect to mitigation risks of human trafficking, slavery and illegal child labor within the supply chain.

Slavery and Human Trafficking Statement – 2016: This Slavery and Human Trafficking Statement was approved by the respective boards of directors of Jazz Pharmaceuticals Ireland Limited and Jazz Pharmaceuticals UK Limited on 20 December 2016, and constitutes the slavery and human trafficking statement of these Jazz subsidiaries for the financial year ending 31 December 2016.

Slavery and Human Trafficking Statement - 2016